Adrenomedullin: A smart road from pheochromocytoma to treatment of pulmonary hypertension

European Respiratory Journal

Volumn 24, Issue 4, 2004, Pages 518-520

  Westphal, Martin ^a   Booke, M ^b   Dinh Xuan, A T ^c  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Dept of Anesthesiology   (Germany)

^c Hôpital Cochin ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN RECEPTOR LIKE RECEPTOR; CYCLIC AMP; ENDOTHELIN 1; G PROTEIN COUPLED RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; NITRIC OXIDE; OXYGEN; PROADRENOMEDULLIN; PROSTAGLANDIN DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; CARDIOPULMONARY HEMODYNAMICS; CARDIOVASCULAR DISEASE; DISEASE EXACERBATION; DRUG MECHANISM; EDITORIAL; EXERCISE; HUMAN; HYPOTENSION; HYPOXEMIA; HYPOXIC LUNG VASOCONSTRICTION; INTENSIVE CARE; LUNG ARTERY PRESSURE; LUNG PERFUSION; LUNG VASCULAR RESISTANCE; LUNG VENTILATION; MEAN ARTERIAL PRESSURE; MICROVASCULATURE; NEBULIZATION; NONHUMAN; OXYGEN TRANSPORT; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS; SEPSIS; SYSTEMIC CIRCULATION;

ADRENAL GLAND NEOPLASMS; ADRENOMEDULLIN; ANIMALS; ANTIHYPERTENSIVE AGENTS; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PULMONARY; PEPTIDES; PHEOCHROMOCYTOMA; PULMONARY CIRCULATION;

EID: 6444235220     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.10060404     Document Type: Editorial

References (24)

1. Kitamura K, Kangawa K, Kawamoto M, et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192: 553-560.
2. Hinson JP, Kapas S, Smith DM. Adrenomedullin, a multi-functional regulatory peptide. Endocr Rev 2000; 21: 138-167.
3. Kobayashi H, Itoh S, Yanagita T, Yokoo H, Sugano T, Wada A. Expression of adrenomedullin and proadrenomedullin N-terminal 20 peptide in PC12 cells after exposure to nerve growth factor. Neuroscience 2004; 125: 973-980.
4. Kitamura K, Kangawa K, Eto T. Adrenomedullin and PAMP: discovery, structures, and cardiovascular functions. Microsc Res Tech 2002; 57: 3-13.
5. Marutsuka K, Hatakeyama K, Sato Y, Yamashita A, Sumiyoshi A, Asada Y. Immunohistological localization and possible functions of adrenomedullin. Hypertens Res 2003; 26: S33-S40.
6. Michibata H, Mukuyama M, Tanaka I, et al. Autocrine/paracrine role of adrenomedullin in cultured endothelial and mesangial cells. Kidney Int 1998; 53: 979-985.
7. Sakai K, Saito K, Ishizuka N. Adrenomedullin synergistically interacts with endogenous vasodilators in rats: a possible role of K(ATP) channels. Eur J Pharmacol 1998; 359: 151-159.
8. Yang BC, Lippton H, Gumusel B, Hyman A, Mehta JL. Adrenomedullin dilates rat pulmonary artery rings during hypoxia: role of nitric oxide and vasodilator prostaglandins, J Cardiovasc Pharmacol 1996; 28: 458-462.
9. Hayakawa H, Hirata Y, Kakoki M, et al. Role of nitric oxide-cGMP pathway in adrenomedullin-induced vasodilation in the rat. Hypertension 1999; 33: 689-693.
10. Kandler MA, Von der Hardt K, Mahfoud S, et al. Pilot intervention: aerosolized adrenomedullin reduces pulmonary hypertension. J Pharmacol Exp Ther 2003; 306: 1021-1026.
11. Beltowski J, Jamroz A. Adrenomedullin - what do we know 10 years since its discovery? Pol J Pharmacol 2004; 56: 5-27.
12. Westphal M, Stubbe H, Bone HG, et al. Hemodynamic effects of exogenous adrenomedullin in healthy and endotoxemic sheep. Biochem Biophys Res Commun 2002; 296: 134-138.
13. von der Hardt K, Kandler MA, Chada M, et al. Brief adrenomedullin inhalation leads to a sustained reduction of pulmonary artery pressure. Eur Respir J 2004; 24: 615-623.
14. Nagaya Y, Okumara H, Uematsu M, et al. Repeated inhalation of adrenomedullin ameliorates pulmonary hypertension and survival in monocrotaline rats. Am J Physiol Heart Circ Physiol 2003; 285: H2125-H2131.
15. Nakanishi K, Osada H, Uenoyama M, et al. Expressions of adrenomedullin mRNA and protein in rats with hypobaric hypoxia-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 2004; 286: H2159-H2168.
16. Nagaya N, Nishikimi T, Uematsu M, et al. Haemodynamic and hormonal effects of adrenomedullin in patients with pulmonary hypertension. Heart 2000; 84: 653-658.
17. Nagaya N, Kyotani S, Uematsu M, et al. Effects of adrenomedullin inhalation on hemodynamics and exercise capacity in patients with idiopathic pulmonary arterial hypertension. Circulation 2004; 109: 351-306.
18. Eddahibi S, Adnot S. Endothelins and pulmonary hypertension, what directions for the near future? Eur Respir J 2001; 18: 1-4.
19. Hanze J, Groneberg DA, Rose F, et al. Genomic organization and regulation of human 7-helix transmembrane receptor which is expressed in pulmonary epithelial cells and induced in hypoxia. Biochem Biophys Res Commun 2002; 291: 1160-1165.
20. Booke M, Bradford DW, Hinder F, et al. Effects of inhaled nitric oxide and nebulized prostacyclin on hypoxic pulmonary vasoconstriction in anesthetized sheep. Crit Care Med 1996; 24: 1841-1148.
21. Wu R, Zhou M, Wang P. Adrenomedullin and adrenomedullin binding protein-1 downregulate TNF-alpha in macrophage cell line and rat Kupffer cells. Regul Pept 2003; 112: 19-26.
22. Koo DJ, Yoo P, Cioffi WG, Bland KI, Chaudry IH, Wang P. Mechanism of the beneficial effects of pentoxifyllline during sepsis: maintainance of adrenomedullin responsiveness and downregulation of proinflammatory cytokines. J Surg Res 2000; 91: 70-76.
23. Yang S, Zhou M, Chaudry IH, Wang P. Novel approach to prevent the transition from the hyperdynamic phase to the hypodynamic phase of sepsis: role of adrenomedullin and adrenomedullin binding protein-1. Ann Surg 2002; 236: 625-633.
24. Ohbayashi H, Suito H, Yoshida N, Ilto Y, Kume H, Yamaki K. Adrenomedullin inhibits ovalbumin-induced bronchoconstriction and airway microvascular leakage in guinea-pigs. Eur Respir J 1999; 14: 1076-1081.